Key Highlights

Risk & Performance

Pipeline Risk Assessment

Based on historical performance

Moderate Risk

Score: 50/100

Failure Rate

12.5%

1 terminated/withdrawn out of 8 trials

Success Rate

50.0%

-36.5% vs industry average

Late-Stage Pipeline

0 trials in Phase 3/4

Results Transparency

100%

1 of 1 completed trials have results

Key Signals

5 recruiting1 with results

Enrollment Performance

Analytics

Phase 1

4(50.0%)

Phase 2

2(25.0%)

N/A

2(25.0%)

8Total

Phase 1(4)

Phase 2(2)

N/A(2)

Activity Timeline

Global Presence

Loading network data...

Clinical Trials (8)

Showing 8 of 8 trials

NCT03988283Phase 1Recruiting

Neoepitope-based Personalized DNA Vaccine Approach in Pediatric Patients With Recurrent Central Nervous System Tumors

Role: collaborator

NCT06158828Phase 1Recruiting

Pilot Study of Memory-like Natural Killer (ML NK) Cells After TCRαβ T Cell Depleted Haploidentical Transplant in AML

Role: collaborator

NCT03068819Phase 1Completed

Cytokine Induced Memory-like NK Cell Adoptive Therapy for Relapsed AML After Allogeneic Hematopoietic Cell Transplant

Role: collaborator

NCT05521984Phase 1Recruiting

Targeting Pediatric Brain Tumors and Relapsed/Refractory Solid Tumors With Sodium Glucose Cotransporter 2 Inhibitors (SGLT2i)

Role: collaborator

NCT02914067Not ApplicableRecruiting

Cognitive Biomarkers in Pediatric Brain Tumor Patients

Role: collaborator

NCT07097506Phase 2Recruiting

Effect of Ketone Esters on Liver Fat Content and Metabolic Function

Role: collaborator

NCT05829239Phase 2Withdrawn

ADI-PEG20, Obesity and Prediabetes

Role: collaborator

NCT05242224Not ApplicableActive Not Recruiting

Evolutionary Nutrition Pilot: Enhancing Fetal Growth and Brain Development

Role: collaborator

All 8 trials loaded